Rallybio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Rallybio and other ETFs, options, and stocks.

About RLYB

Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. 

CEO
Stephen Uden
CEOStephen Uden
Employees
25
Employees25
Headquarters
New Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded
2018
Founded2018
Employees
25
Employees25

RLYB Key Statistics

Market cap
55.65M
Market cap55.65M
Price-Earnings ratio
-4.12
Price-Earnings ratio-4.12
Dividend yield
Dividend yield
Average volume
516.37K
Average volume516.37K
High today
$10.79
High today$10.79
Low today
$10.37
Low today$10.37
Open price
$10.37
Open price$10.37
Volume
151.99K
Volume151.99K
52 Week high
$11.49
52 Week high$11.49
52 Week low
$1.76
52 Week low$1.76

Stock Snapshot

The current Rallybio(RLYB) stock price is $10.52, with a market capitalization of 55.65M. The stock trades at a price-to-earnings (P/E) ratio of -4.12.

On 2026-03-05, Rallybio(RLYB) stock traded between a low of $10.37 and a high of $10.79. Shares are currently priced at $10.52, which is +1.4% above the low and -2.5% below the high.

The Rallybio(RLYB)'s current trading volume is 151.99K, compared to an average daily volume of 516.37K.

During the past year, Rallybio(RLYB) stock moved between $1.76 at its lowest and $11.49 at its peak.

During the past year, Rallybio(RLYB) stock moved between $1.76 at its lowest and $11.49 at its peak.

RLYB News

TipRanks 3d
Rallybio to Merge with Candid Therapeutics in All-Stock Deal

An announcement from Rallybio ( (RLYB) ) is now available. Rallybio Corporation and Candid Therapeutics announced on March 2, 2026 that Rallybio will acquire C...

TipRanks 6d
Rallybio’s RLYB116 Clears Phase 1 Milestone, Sharpening Its Autoimmune Pipeline

Rallybio Corporation (RLYB) announced an update on their ongoing clinical study. Rallybio (RLYB) has completed a Phase 1 trial titled “Multiple Dose Study to E...

People also own

Based on the portfolios of people who own RLYB. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.